Medindia LOGIN REGISTER
Medindia
Advertisement

Aristea Therapeutics to Present at the 2019 BIO Investor Forum

Wednesday, October 16, 2019 Drug News
Advertisement
SAN DIEGO, Oct. 15, 2019 /PRNewswire/ -- Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat serious inflammatory diseases, today announced that the Company will present at the 2019 BIO Investor Forum being held October 22-23, 2019 in San Francisco, CA. Dr. James Mackay, President and CEO of Aristea, will present at the conference and meet with investors.
Advertisement

Presentation Details:

Date/Time: October 23, 2019, 9:30 am PTLocation: The Westin St. Francis, San Francisco, CA
Advertisement

About Aristea Therapeutics

Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage immunology focused drug development company developing novel therapies to treat serious inflammatory diseases. The Aristea team is leveraging its broad industry expertise and proven success in drug development to form synergistic partnerships and build a pipeline of novel drugs. Aristea's lead program, RIST4721, is currently in Phase 2 clinical development. Aristea is headquartered in San Diego, CA. To learn more, please visit www.aristeatx.com.

Contact:

Amy ConradJuniper Point858-366-3243[email protected]

 

Cision View original content:http://www.prnewswire.com/news-releases/aristea-therapeutics-to-present-at-the-2019-bio-investor-forum-300938770.html

SOURCE Aristea Therapeutics

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close